Microbial Collagenase: Clinical Trials

17 trials of Microbial Collagenase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 1 unknown, 1 withdrawn. 17 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 217Completed 15, Unknown 1, Withdrawn 1
Phase 11Completed 1

Follow Microbial Collagenase: new trials by email Literature Review of Microbial Collagenase trials Research Report on Microbial Collagenase

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)
Collagenase Clostridium Histolyticum (CCH), Placebo - Plantar Fasciitis
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company2312024-01-032025-09-30
CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques
collagenase clostridium histolyticum - Edematous Fibrosclerotic Panniculopathy, Cellulite
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company352020-10-012022-09-28
Clostridium Histolyticum Collagenase Injection for Urethral Disease
Clostridium Histolyticum Collagenase, Saline - Urethral Stricture
Phase 2CompletedUniversity of South Florida52020-05-222023-11-03
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
collagenase clostridium histolyticum (CCH) - Edematous Skin
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company642018-09-182023-09-07
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
Collagenase Clostridium Histolyticum - Edematous Fibrosclerotic Panniculopathy, Cellulite
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company1582017-11-172020-12-29
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Collagenase Clostridium Histolyticum - Edematous Fibrosclerotic Panniculopathy, Cellulite
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company2592016-10-052020-11-24
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, Placebo Comparator - Edematous Fibrosclerotic Panniculopathy, Cellulite
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company3752016-02-012017-11-06
Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma
AA4500, placebo - Lipoma
Phase 2CompletedGerut, Zachary, M.D.192014-08-012017-02-23
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
Collagenase clostridium histolyticum, Placebo - Dupuytren's Disease
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company762014-07-012017-10-05
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
Collagenase Clostridium Histolyticum, Placebo - Adhesive Capsulitis, Frozen Shoulder
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company3222013-11-012017-10-05
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Collagenase Clostridium Histolyticum, Placebo - Edematous Fibrosclerotic Panniculopathy (EFP)
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company1502013-10-012017-10-05
A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma
Collagenase Clostridium Histolyticum - Lipoma
Phase 2CompletedZachary Gerut142012-05-012016-10-06
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
AA4500 0.29 mg/1 mL, AA4500 0.58 mg/2 mL, AA4500 0.58 mg/1 mL - Adhesive Capsulitis, Frozen Shoulder
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company502011-11-012017-10-05
Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
AA4500 - Peyronie's Disease
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company202011-09-012017-10-05
Injectable Collagenase For Burns' Associated Contracture
Xiaflex (FDA approved collagenase) - Burn's Associated Contracture
Phase 2UnknownSheba Medical Center102011-03-012010-11-10
Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder)
Collagenase - Adhesive Capsulitis, Frozen Shoulder
Phase 2WithdrawnStony Brook University2006-01-012019-10-03
Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand
Collagenase, Collagenase injection - Adhesion of Flexor Tendon of Hand
Phase 1 / Phase 2CompletedStony Brook University32005-01-012016-04-21

Conditions studied

Cellulite (6)  ·  Bursitis (3)  ·  Lipoma (2)  ·  Cutis Laxa (1)  ·  Dupuytren Contracture (1)  ·  Fasciitis, Plantar (1)  ·  Penile Induration (1)  ·  Shoulder Pain (1)  ·  Urethral Stricture (1)

Sponsors

Endo USA Inc., a Keenova Therapeutics Company (11)  ·  Stony Brook University (2)  ·  Gerut, Zachary, M.D. (1)  ·  Sheba Medical Center (1)  ·  University of South Florida (1)  ·  Zachary Gerut (1)

Countries

United States (16)  ·  Australia (2)  ·  Israel (1)

Top investigators

Marie A Badalamente, PhD (2)  ·  Veronica Urdaneta, MD MPH (2)  ·  David Hernandez (1)  ·  Edward Wang, MD (1)  ·  George Omburo (1)  ·  Gregory J. Kaufman, MD (1)  ·  Lucas R Wiegand, MD (1)  ·  Mike McLane (1)  ·  Mike McLane, PhD (1)  ·  Neil H Schusterman, MD FACP (1)  ·  Neil H Shusterman, MD FACP (1)  ·  Zachary E Gerut, M.D. (1)  ·  Zachary E Gerut, MD (1)

Results publications

PMID 15541123, PMID 17437780, PMID 17617144, PMID 19726771, PMID 21315996, PMID 23376148, PMID 24745607, PMID 26126692, PMID 26491251, PMID 28854973, PMID 9679876